Skip to content

This content is in French.

HIV and Dual Therapy: a promising step towards maintaining viral suppression

5 décembre 2024

HIV and Dual Therapy: a promising step towards maintaining viral suppression
The introduction of dual therapies in HIV treatment marks a significant advance in optimizing care. By reducing the number of drugs used, these simplified regimens improve tolerance, lower costs, and simplify treatment management. Compared to traditional triple therapies, dual therapies promote better adherence and allow for personalized care tailored to patients' needs, while maintaining comparable efficacy in viral suppression. This approach combines innovation, patient comfort, and sustainability for healthcare systems.  

Sign in to read the rest

Reserved for healthcare professionals, free registration.

Scientific reference

Marinosci, A., et al. (2024). Efficacy and Safety of Dolutegravir Plus Emtricitabine vs Combined Antiretroviral Therapy for the Maintenance of HIV Suppression: Results Through Week 144 of the SIMPL'HIV Trial. Open forum infectious diseases, 11(11), ofae61

View the source